Dental stem cells show mixed comparative advantages in animal studies
Reported repair outcomes often favored dental sources, but some comparisons favored other cells or found similar results.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Dental-derived stem cells often performed better than cells from other sources in animal models of disease and tissue repair. That pattern was not universal: some studies found similar results or slightly better outcomes with other cell types. These preclinical comparisons cannot establish whether dental-derived cells provide safer or more effective treatment for people.
The authors reported variation in methods and limited standardization. This abstract-based summary provides no study-level effect sizes, and animal outcomes cannot establish human clinical effectiveness or safety.
What the review compared
Researchers compared several kinds of dental-derived cells, including cells from dental pulp, gums and periodontal ligaments. The review covered multiple body systems, so it addressed a broad family of applications rather than a single disease.
Different models, different outcomes
Reported outcomes included bone formation, nerve protection, blood-vessel formation, tissue repair and regulation of inflammation. Because these outcomes and disease models differed, the findings do not identify a universally superior stem-cell source.
The original publication
Therapeutic potential of dental mesenchymal stem cells versus mesenchymal stem cells from other sources: a systematic review of animal studies.
Daneshvar A, MomeniAmjadi A, Azadi A et al.
BMC Oral Health · 2025
- PubMed ID
- 41354918
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.